InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
1.150
-0.030 (-2.54%)
At close: May 1, 2026, 4:00 PM EDT
1.080
-0.070 (-6.09%)
Pre-market: May 4, 2026, 8:06 AM EDT
InspireMD Revenue
In the year 2025, InspireMD had annual revenue of $8.98M with 28.11% growth. InspireMD had revenue of $3.15M in the quarter ending December 31, 2025, with 61.57% growth.
Revenue (ttm)
$8.98M
Revenue Growth
+28.11%
P/S Ratio
6.17
Revenue / Employee
$70,701
Employees
127
Market Cap
55.39M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.98M | 1.97M | 28.11% |
| Dec 31, 2024 | 7.01M | 804.00K | 12.96% |
| Dec 31, 2023 | 6.21M | 1.03M | 20.00% |
| Dec 31, 2022 | 5.17M | 676.00K | 15.04% |
| Dec 31, 2021 | 4.50M | 2.01M | 80.89% |
| Dec 31, 2020 | 2.49M | -1.24M | -33.22% |
| Dec 31, 2019 | 3.72M | 120.00K | 3.33% |
| Dec 31, 2018 | 3.60M | 840.00K | 30.42% |
| Dec 31, 2017 | 2.76M | 867.00K | 45.78% |
| Dec 31, 2016 | 1.89M | -416.00K | -18.01% |
| Dec 31, 2015 | 2.31M | -508.00K | -18.03% |
| Dec 31, 2014 | 2.82M | -3.30M | -53.95% |
| Dec 31, 2013 | 6.12M | 1.25M | 25.57% |
| Jun 30, 2013 | 4.87M | -476.00K | -8.90% |
| Jun 30, 2012 | 5.35M | -655.00K | -10.91% |
| Dec 31, 2011 | 6.00M | 1.06M | 21.32% |
| Dec 31, 2010 | 4.95M | 1.54M | 45.09% |
| Dec 31, 2009 | 3.41M | - | - |
| Jun 30, 2009 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Pulmonx | 88.55M |
| LENSAR | 58.44M |
| electroCore | 32.03M |
| Sensus Healthcare | 27.48M |
| Baird Medical Investment Holdings | 22.54M |
| Spectral AI | 19.65M |
| Elutia | 12.29M |
NSPR News
- 2 days ago - InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System - GlobeNewsWire
- 2 days ago - InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System - GlobeNewsWire
- 6 days ago - InspireMD to Announce First Quarter 2026 Financial Results - GlobeNewsWire
- 19 days ago - InspireMD Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 4 weeks ago - InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 weeks ago - InspireMD Earnings Call Transcript: Q4 2025 - Transcripts
- 6 weeks ago - InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire